Glycine-Histidine-Lysine Copper Complex — a naturally occurring copper-binding tripeptide studied for collagen synthesis, wound healing, skin regeneration, and anti-ageing gene expression.
What is GHK-Cu and why is it considered one of the most versatile naturally occurring anti-ageing peptides? GHK-Cu, or Glycine-Histidine-Lysine copper complex, is a naturally occurring tripeptide found in human plasma, saliva, and urine. It forms a complex with copper ions and is studied for its wide-ranging effects on wound healing, collagen synthesis, skin regeneration, and — importantly — its ability to modulate gene expression in ways associated with healthy ageing.
| TL;DRGHK-Cu (Glycine-Histidine-Lysine copper complex) is a naturally occurring tripeptide that binds copper ions and is found in human plasma, saliva, and urine. Plasma levels decline significantly with age. Research demonstrates GHK-Cu’s ability to stimulate collagen synthesis, accelerate wound healing, promote skin regeneration, and modulate the expression of genes involved in inflammation and cellular repair. It is used in anti-ageing skincare, biohacking protocols, and regenerative research. |
| Parameter | Detail |
| Full name | Glycine-Histidine-Lysine copper complex |
| Abbreviation | GHK-Cu |
| Structure | Tripeptide — 3 amino acids: Gly-His-Lys bound to copper (Cu2+) |
| Natural source | Human plasma, saliva, urine. Plasma levels decline with age. |
| Primary mechanism | Copper-dependent collagen synthesis stimulation; gene expression modulation |
| Research status | Preclinical and topical clinical evidence; extensive cosmeceutical research |
| Purity standard | Greater than 98% for research grade |
| Longevity relevance | Collagen synthesis, wound healing, anti-inflammatory gene modulation, skin regeneration |
GHK-Cu is the copper complex of the tripeptide Glycine-Histidine-Lysine (GHK). It occurs naturally in the human body, found in plasma at concentrations of around 200 nanograms per millilitre in young adults. It is also present in saliva and urine, where it plays roles in tissue maintenance and immune modulation.
The peptide was first identified by Loren Pickart in 1973 during research on the effects of human albumin on liver cell function. Pickart’s subsequent decades of research established GHK-Cu as a biologically active peptide with broad regenerative and anti-ageing properties.
One of the most significant findings in GHK-Cu research is its age-related decline in plasma concentration. Research indicates that plasma GHK levels fall from approximately 200 ng/mL in young adults to around 80 ng/mL by age 60 — a reduction of approximately 60%.
| Why the Decline MattersThe age-related fall in GHK-Cu plasma levels correlates with well-documented changes in tissue repair capacity, wound healing speed, and skin structure that occur with ageing. This correlation positions GHK-Cu as both a biomarker of biological ageing and a potential intervention target for anti-ageing and longevity protocols. |
Research by Loren Pickart and colleagues, published in Organogenesis in 2012, analysed GHK-Cu’s effects on gene expression using genome-wide analysis. The findings suggested that GHK-Cu modulates the expression of over 4,000 human genes — with the majority of effects pointing toward upregulation of repair and regeneration pathways and downregulation of inflammatory and oncogenic pathways.
| Gene Expression Category | Direction of GHK-Cu Effect |
| Collagen synthesis genes | Upregulated |
| Wound repair and tissue remodelling | Upregulated |
| Anti-inflammatory pathways | Upregulated (regulatory) |
| Inflammatory cytokine expression | Downregulated |
| Oncogene expression | Downregulated in multiple pathway analyses |
| Antioxidant defence genes | Upregulated |
| Research Area | Key Finding |
| Collagen synthesis | Multiple studies have confirmed GHK-Cu stimulates collagen production in human fibroblasts, with research demonstrating increased collagen types I and III synthesis. |
| Wound healing | Clinical and preclinical studies have documented accelerated wound healing and improved tissue remodelling in GHK-Cu-treated models. |
| Skin regeneration | Controlled studies on topical GHK-Cu formulations have shown improvements in skin density, thickness, and elasticity in ageing subjects. |
| Gene expression | Pickart et al. (2012, Organogenesis) reported GHK-Cu modulates expression of over 4,000 human genes in directions consistent with tissue repair and anti-ageing. |
| Nerve regeneration | Preclinical studies have suggested GHK-Cu may support peripheral nerve regeneration, broadening its potential research applications. |
GHK-Cu occupies a distinctive position in biohacking and longevity research because it is one of the few peptides with both strong topical evidence and emerging systemic research. Its natural occurrence in the body and well-characterised mechanism make it a credible anti-ageing intervention.
| Application Route | Key Considerations |
| Topical (skincare) | Well-evidenced for skin collagen, elasticity, and wound healing. Absorbed through skin into superficial tissue layers. Standard in cosmeceutical research. |
| Subcutaneous (systemic) | Used in research protocols for systemic connective tissue and anti-inflammatory effects. Less clinical evidence than topical route but growing biohacking use. |
| Quality Parameter | Specification |
| Minimum purity | Greater than 98% by reversed-phase HPLC |
| Molecular weight | 340.38 Da (free tripeptide); 403.9 Da as copper complex |
| Verification method | Reversed-phase HPLC (C18 column, 214nm and 280nm for histidine); MS confirmation |
| Copper content | Should be verified — copper-to-peptide ratio affects biological activity |
| CoA requirement | HPLC chromatogram, MS data, copper content verification, batch number |
| Standalone Factual Statements |
GHK-Cu stimulates collagen types I, III, and IV synthesis, promotes elastin production, and modulates matrix metalloproteinase activity — improving the balance of collagen synthesis and degradation. Clinical studies on topical formulations have documented improvements in skin density, thickness, elasticity, and wound healing speed in ageing subjects.
Yes. GHK-Cu is a naturally occurring tripeptide found in human plasma at concentrations around 200 ng/mL in young adults. It is also present in saliva and urine. Plasma concentrations decline by approximately 60% by age 60, which correlates with age-related reductions in tissue repair capacity.
GHK-Cu and BPC-157 both support tissue repair but through different mechanisms and with different primary targets. GHK-Cu acts via copper-dependent collagen synthesis stimulation and broad gene expression modulation, with particularly strong evidence for skin and connective tissue. BPC-157 works via growth hormone receptor upregulation and VEGF activation, with stronger evidence for tendon, gut, and muscle repair.
A research-grade GHK-Cu CoA should include HPLC purity data with chromatogram, mass spectrometry confirmation of molecular identity, verification of copper content (as the copper ratio affects biological activity), batch number, and storage specifications. Purity should be greater than 98%.
| Term | Definition |
| GHK-Cu | Glycine-Histidine-Lysine copper complex. A naturally occurring tripeptide that binds copper ions and is studied for collagen synthesis, wound healing, and anti-ageing gene modulation. |
| Tripeptide | A peptide consisting of three amino acids. GHK-Cu is a tripeptide with the sequence Gly-His-Lys. |
| Lysyl oxidase | A copper-dependent enzyme that crosslinks collagen and elastin fibres. GHK-Cu’s copper-delivery function supports lysyl oxidase activity in connective tissue. |
| Matrix metalloproteinase (MMP) | Enzymes that degrade extracellular matrix components including collagen. GHK-Cu modulates MMP activity to support the balance of collagen synthesis and breakdown. |
| Collagen types I, III, IV | The primary structural collagens in skin and connective tissue. Type I provides tensile strength; Type III supports elasticity; Type IV forms basement membranes. All are stimulated by GHK-Cu. |
| Cosmeceutical | A cosmetic product with biologically active ingredients that have pharmaceutical-like effects on skin. GHK-Cu is widely used in cosmeceutical skincare for its collagen-stimulating properties. |
| TNF-alpha | Tumour Necrosis Factor alpha. A pro-inflammatory cytokine. GHK-Cu research has demonstrated downregulation of TNF-alpha expression, contributing to its anti-inflammatory profile. |
| Related Entity Pages-> Peptides — The Master Reference Guide hplcpeptides.com/wiki/peptides-> BPC-157 — Tissue Repair and Gut Health hplcpeptides.com/wiki/bpc-157-> Epithalon — Anti-Ageing and Telomere Research hplcpeptides.com/wiki/epithalon
-> Dr William Seeds — Peptide Therapy Protocols hplcpeptides.com/wiki/dr-william-seeds -> Peptide Testing — Purity, Quantity and Integrity hplcpeptides.com/wiki/peptide-testing -> MOTS-c — Mitochondrial Health and Longevity hplcpeptides.com/wiki/mots-c -> Collagen Peptides hplcpeptides.com/wiki/collagen-peptides |
| About This PageThis entity page is maintained by the HPLC Peptides editorial team. All research references are from preclinical and cosmeceutical research. This page does not constitute medical advice. |
hplcpeptides.com/wiki/ghk-cu | Entity Page v1.0 | April 2026
